The goals of Project 4 are to analyze how the TIM gene alleles influence the confornnation and ligand binding properties ofthe TIM proteins, to uncover new ligand binding motif by structure deternnination and to understand how those motifs are engaged in ligand recognition. Our recent structure determination of murine TIM-1, TIM-2 and TIM-4 proteins have provided relevant insight on ligand binding by the TIM proteins. The structures identified a novel TIM-TIM interaction and a critical ligand binding cavity with a metal ion (metal ion-dependent ligand binding site, MILIBS). Ligands such as phosphatidylserine (PtdSer) bind into this unique pocket in TIM-1 and TIM-4 proteins. Recently we found that the TIM-3 protein binds also to PtdSer and that the binding affinity is TIM-3 allele dependent. We will study the influence ofthe mouse and human TIM-1 polymorphism on PtdSer recognition. The effects on cell survival or activation mediated by intracellular signals triggered by the binding of PtdSer to TIM proteins on the cell surface, and the differences among alleles will be analyzed together with other projects of the Program using different experimental models. We will determine the relevance ofthe MILIBS in ligand recognition. We will identify antibodies recognizing the MILIBS and blocking TIM protein functions. They will be used in other program projects for functional studies in animal models. We will characterize the involvement of this site in HAV binding and in homotypic TIM-TIM interactions. We will determine whether PtdSer containing vesicles can mediate TIMTIM interactions. We observed that the MILIBS was engaged on the accumulation ofthe mTIM-1 protein inside ofthe cell. We will extend the analysis of TIM protein trafficking to other TIM proteins and identify the nature ofthe intracellular vesicles containing TIM proteins. We will carry out structural studies on TIM proteins and ligands, and biophysical studies on TIM protein binding to PtdSer in cellular membranes. The structures will uncover ligand and antibody binding footprints and identify new motifs engaged on ligand recognition. We will carry out biophysical studies to uncover penetration ofthe MILIBS into a lipid bilayer upon TIM protein binding to membrane anchored PtdSer. Using structural techniques and mAbs we will identify conformations of the TIM proteins on the cell surface and its relation to domain composition, alleles and cell environment. The differential display of a TIM protein to ligands on the cell surface might be of relevance for modulating TIM protein functions.

Public Health Relevance

The TIM protein structures provide relevant insights on ligand recognition and on the function of the TIM proteins in the immune system. Analysis of the influence of TIM gene polymorphisms on TIM protein functions will allow the identification of molecular mechanisms leading to the development of atopic diseases and related inflammatory reactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
7P01AI054456-10
Application #
8831798
Study Section
Special Emphasis Panel (ZAI1-RRS-I)
Project Start
Project End
Budget Start
2014-02-01
Budget End
2014-06-30
Support Year
10
Fiscal Year
2013
Total Cost
$43,373
Indirect Cost
$5,824
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Foks, Amanda C; Engelbertsen, Daniel; Kuperwaser, Felicia et al. (2016) Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol 36:456-65
Kim, Hye Young; Umetsu, Dale T; Dekruyff, Rosemarie H (2016) Innate lymphoid cells in asthma: Will they take your breath away? Eur J Immunol 46:795-806
Brauner, Eran; Gunda, Viswanath; Vanden Borre, Pierre et al. (2016) Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer. Oncotarget 7:17194-211
Mahoney, Kathleen M; Rennert, Paul D; Freeman, Gordon J (2015) Combination cancer immunotherapy and new immunomodulatory targets. Nat Rev Drug Discov 14:561-84
Mahoney, Kathleen M; Freeman, Gordon J; McDermott, David F (2015) The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Clin Ther 37:764-82
Echbarthi, Meriem; Zonca, Manuela; Mellwig, Rachel et al. (2015) Distinct Trafficking of Cell Surface and Endosomal TIM-1 to the Immune Synapse. Traffic 16:1193-207
Kroy, Daniela C; Ciuffreda, Donatella; Cooperrider, Jennifer H et al. (2014) Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors. Gastroenterology 146:550-61
Xiao, Yanping; Yu, Sanhong; Zhu, Baogong et al. (2014) RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. J Exp Med 211:943-59
Recacha, Rosario; Jiménez, David; Tian, Li et al. (2014) Crystal structures of an ICAM-5 ectodomain fragment show electrostatic-based homophilic adhesions. Acta Crystallogr D Biol Crystallogr 70:1934-43
Angiari, Stefano; Donnarumma, Tiziano; Rossi, Barbara et al. (2014) TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity 40:542-53

Showing the most recent 10 out of 38 publications